Stephan R Vavricka
Overview
Explore the profile of Stephan R Vavricka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
208
Citations
6334
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vavricka S, Greuter T
Aliment Pharmacol Ther
. 2024 Oct;
60(11-12):1613-1614.
PMID: 39415692
No abstract available.
2.
Adamina M, Minozzi S, Warusavitarne J, Buskens C, Chaparro M, Verstockt B, et al.
J Crohns Colitis
. 2024 Jun;
18(10):1556-1582.
PMID: 38878002
This article is the second in a series of two publications on the European Crohn's and Colitis Organisation [ECCO] evidence-based consensus on the management of Crohn's disease. The first article...
3.
Gordon H, Minozzi S, Kopylov U, Verstockt B, Chaparro M, Buskens C, et al.
J Crohns Colitis
. 2024 Jun;
18(10):1531-1555.
PMID: 38877997
No abstract available.
4.
Vavricka S
Ther Umsch
. 2023 Dec;
80(9):393-397.
PMID: 38095252
Chronic inflammatory bowel diseases (IBD) are inflammatory gastrointestinal disorders that are not limited to the gastrointestinal tract. Many different organ systems may be involved, which makes IBD a systemic disease....
5.
Weisshof R, Vavricka S, Pouillon L, Braegger F, Roset M, Bent-Ennakhil N, et al.
BMC Gastroenterol
. 2023 Nov;
23(1):417.
PMID: 38030966
Background: Vedolizumab (VDZ), a gut-selective anti-lymphocyte trafficking integrin antibody, is effective in treating patients with moderately to severely active Crohn's disease (CD). In this study, we examined the real-world effectiveness...
6.
Heil A, Kuehlewindt T, Godat A, Simon H, Simon D, Schreiner P, et al.
Int Arch Allergy Immunol
. 2023 Oct;
185(1):63-72.
PMID: 37866349
Introduction: It is still unknown whether eosinophilic esophagitis (EoE) patients with localized disease are different from those with extended disease. Methods: We evaluated prospectively included patients in the Swiss EoE...
7.
El Hadad J, Schreiner P, Vavricka S, Greuter T
Mol Diagn Ther
. 2023 Oct;
28(1):27-35.
PMID: 37847439
The genetic background of inflammatory bowel disease, both Crohn's disease and ulcerative colitis, has been known for more than 2 decades. In the last 20 years, genome-wide association studies have...
8.
Rossier L, Matter C, Burri E, Galperine T, Hruz P, Juillerat P, et al.
Swiss Med Wkly
. 2023 Sep;
153:40100.
PMID: 37769622
Introduction: Faecal microbiota transplantation (FMT) is an established therapy for recurrent C. difficile infection, and recent studies have reported encouraging results of FMT in patients with ulcerative colitis. Few international...
9.
Hebuterne X, Vavricka S, Thorne H, MacKenzie-Smith L, Laoun R, Burisch J
Inflamm Intest Dis
. 2023 Sep;
8(1):41-49.
PMID: 37711959
Introduction: Patient adherence is a major challenge for the successful management of any chronic disease, and ulcerative colitis (UC) is no exception. Patient adherence is closely related to patient preference...
10.
Lang B, Ledergerber M, Jordi S, Krupka N, Biedermann L, Schreiner P, et al.
Therap Adv Gastroenterol
. 2023 Aug;
16:17562848231179335.
PMID: 37564129
Background: While the detrimental impact of negative emotions on the clinical course of inflammatory bowel disease (IBD) and quality of life has been extensively investigated, evidence for a potential impact...